Home Recalls D-0452-2019
Class II · Moderate risk Terminated Initiated Dec 17, 2018 (8 years ago)
Ipamorelin+Modified GRF 1-29, 9 mg/5mg injection, Rx Only, Promise Pharmacy Compounding…
Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.
Why it was recalled
Lack of sterility assurance.
What was recalled
Ipamorelin+Modified GRF 1-29, 9 mg/5mg injection, Rx Only, Promise Pharmacy Compounding Specialists 31818 US Hwy 19N, Palm Harbor, FL 34684
Recalling firm Promise Pharmacy, LLC
Origin FL, United States
Initiated by Voluntary: Firm initiated
FDA recall number D-0452-2019
What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.
Class II · Moderate risk Terminated Apr 5, 2022
Reason Lack of Assurance of Sterility: deviations from Current Good Manufacturing Practices (CGMP) that call into question the sterility of products…
Class II · Moderate risk Terminated Oct 12, 2021
Reason Lack of assurance of sterility
Class II · Moderate risk Terminated Oct 12, 2021
Reason Lack of assurance of sterility
Class II · Moderate risk Terminated Oct 12, 2021
Reason Lack of assurance of sterility
Class II · Moderate risk Terminated Oct 12, 2021
Reason Lack of assurance of sterility